Clinical trial Recruiting at 1 site Interventional Ages 12 to 18

Culturally adapted DBT skills group for adolescents with emotional disorders

Official title: Cultural Adaptation and Implementation of Dialectical Behavior Therapy Skills Training Group for Adolescents With Emotional Disorders: a Feasibility Study and a Randomized Controlled Trial

Run by Mackay Memorial Hospital · NCT06566235 · Data updated 2026-11-12

This project will test whether a culturally adapted Dialectical Behavior Therapy skills group helps adolescents ages 12–18 with depression, anxiety, or ADHD-related emotional problems more and faster than a Satir-based group.

More Emotional Disorders trials

Quick facts

Study typeInterventional
Ages12 Years to 18 Years
SexAll
Enrollment160 (estimated)
SponsorMackay Memorial Hospital
Academic / other
Locations2 sites (Taipei and 1 other locations)
StatusRecruiting
StartedOctober 24, 2024
Main results expectedJuly 31, 2028
Study endsJuly 31, 2028
Registry record updatedSeptember 8, 2026
Trial IDNCT06566235 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Mandarin-proficient adolescents aged 12–18 with a primary depressive, anxiety disorder, or ADHD diagnosis and elevated symptom scores (PHQ-9 ≥8, GAD-7 ≥8, or SDQ thresholds) who can provide assent and have a consenting parent.

Probably not a fit

Those unlikely to benefit include youths with acute suicidality, psychotic disorders, intellectual disability, insufficient Chinese language skills, or those outside the 12–18 age range.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In year one the team develops a culturally adapted DBT-A skills training using a pilot 15-session program and focus groups. Years two to four use a partially randomized patient preference design to compare the adapted DBT-A-ST group versus a Satir-based group, with participants allocated either by randomization or by preference. Both group interventions run 15 weekly sessions of 120 minutes, target a sample of 160 youths, and include five assessment points (baseline, after 4 and 8 sessions, post-intervention, and 3-month follow-up). Primary outcomes are depression and anxiety severity rated by blinded assessors, with secondary outcomes covering general psychopathology, number of DSM-5 disorders, quality of life, self-report measures, and implementation/process measures.

Why it matters

Potential benefit: If successful, this could offer Mandarin-speaking adolescents a culturally tailored group skills program that reduces depression and anxiety faster and improves overall functioning.

How similar studies have gone: DBT-A has prior evidence for improving adolescent emotion regulation and reducing self-harm, but culturally adapted DBT-A skills training and direct comparisons with Satir-based group therapy are less well studied.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age 12-18 years.
2. Informed consent provided by the youth and one parent.
3. Sufficient Mandarin Chinese proficiency to complete study questionnaires.
4. Total score of PHQ-9 ≥ 8 or GAD-7 ≥ 8, or SDQ total score ≥ 10, or SDQ hyperactivity subscale score ≥ 3.
5. Primary diagnosis of depressive, anxiety disorder, or ADHD based on K-SADS-

   E interview, including:

   Depression (F32-33) Persistent mood disorder (F34) Phobic anxiety disorder (F40) Other anxiety disorder (F41) Adjustment disorders (F43.2) ADHD (F90)
6. Stable medication use for at least four weeks and willingness to maintain stable dosage during the study.
7. Individuals with comorbid emotional disorders are included; comorbidities are not stratified to avoid increasing study design complexity.

Exclusion Criteria:

1. Educational level of elementary school or university.
2. Comorbid intellectual disability or psychotic disorder.
3. Acute suicidality.
4. Insufficient Chinese language skills.
5. Unwillingness to discontinue current psychotherapy.
6. Unwillingness to accept video recording during group therapy.
7. Medication changes during the trial are not exclusionary if judged necessary or clinically important by the treating clinician, to maintain a naturalistic setting.

Where it's running

  • MacKay Memorial Hospital
    Taipei, Taiwan
    Recruiting
  • MacKay Memorial Hospital
    Taipei, Taiwan
    Active not recruiting

Study contacts

  • Principal investigator: Shen-Ing Liu, Ph.D — Mackay Memorial Hospital
  • Study coordinator: Hui-Chun Huang, Ph.D
  • Email: aihch@mmh.org.tw
  • Phone: 886-2-28094661

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.